Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207115 · ClinicalTrials.gov registry record · Phase 2
A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee
A Phase 2 study, sponsored by AbbVie (prior sponsor, Abbott).
- Completed
- Registry status
- Phase 2
- Development phase
- 322
- Enrollment target
NCT01207115 is a Phase 2 study that has completed, run by AbbVie (prior sponsor, Abbott). The registered enrollment target is 322 participants.
The verdict
NCT01207115, a Phase 2 study, has completed, sponsored by AbbVie (prior sponsor, Abbott).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 322 participants
- Enrollment target
Study Summary
To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.
Interventions
- DRUG Placebo
- DRUG Naproxen
- DRUG ABT-652
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207115
The ClinicalTrials.gov registry entry for NCT01207115 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie (prior sponsor, Abbott), which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01207115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01207115 about?
NCT01207115 is a clinical study titled "A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee". To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.
What is the current status of trial NCT01207115?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 322 participants. The study started on 2010-09. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01207115?
The interventions under investigation include: Placebo (DRUG), Naproxen (DRUG), ABT-652 (DRUG).
Who is sponsoring clinical trial NCT01207115?
This trial is sponsored by AbbVie (prior sponsor, Abbott), which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.